Applied BioCode

Applied BioCode Crescimento de EBIT

O Crescimento do EBIT Ano a Ano de Applied BioCode (6598.TW) em 23 de out. de 2026 é 19,57 %. No ano anterior, Crescimento do EBIT Ano a Ano foi -48,72 % — uma variação de -140,16% (superior).

Crescimento de EBIT

19,57 %

YoY

-140,16%

Última atualização:

Crescimento do EBIT Ano a Ano de Applied BioCode é 2025 19,57 % . Crescimento do EBIT Ano a Ano de Applied BioCode era 2024 -48,72 % . Ele decresce em -140,16% superior em comparação com o ano anterior.

A Applied BioCode Crescimento de EBIT História

  • 3 anos

  • 10 anos

  • 25 anos

  • Max

Crescimento de EBIT
Data
Crescimento de EBIT
1 de jan. de 2018
-1,43 TWD
1 de jan. de 2019
-2,18 TWD
1 de jan. de 2020
63,74 TWD
1 de jan. de 2021
-63,68 TWD
1 de jan. de 2022
-12,09 TWD
1 de jan. de 2023
-2,63 TWD
1 de jan. de 2024
-48,72 TWD
1 de jan. de 2025
19,57 TWD
A Applied BioCode Crescimento de EBIT História
ANOCrescimento de EBITYoY
19,57 %-140,16%
-48,72 %+1.755,95%
-2,63 %-78,28%
-12,09 %-81,02%
-63,68 %-199,91%
63,74 %-3.024,96%
-2,18 %+52,11%
-1,43 %-95,98%
-35,61 %-394,08%
12,11 %-133,65%
-35,98 %—

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Applied BioCode Análise de ações

O que Applied BioCode faz? Applied BioCode Corp is a California-based company that focuses on the development and marketing of diagnostic instruments and tests. The company was founded in 2004 by an experienced management team and has since developed a number of groundbreaking technologies to improve the diagnosis of diseases such as cancer, infectious diseases, and autoimmune diseases. The business model of Applied BioCode Corp is based on the development of innovative diagnostic instruments and test systems based on proprietary technologies. The company has a strong partnership with a leading manufacturer of diagnostic automation systems, allowing a wide range of tests for various diseases to be offered. Applied BioCode Corp also works closely with leading research and development organizations to leverage the latest insights in the field of diagnostics. One of the divisions of Applied BioCode is molecular diagnostics, which is an essential component of modern medicine. Molecular diagnostics enables the detection of genetic changes and deviations related to diseases. Applied BioCode's technology allows for rapid and precise identification of pathogens in clinical samples such as blood, urine, and tissue samples. Another important area for Applied BioCode is infectious disease diagnostics. The company has developed a range of test systems based on a variety of infectious diseases such as influenza, tuberculosis, and sexually transmitted diseases such as chlamydia and gonorrhea. These tests can be performed individually or as a group to facilitate disease diagnosis and improve treatment. Applied BioCode also offers tests for the detection of oncological markers. These tests are crucial for the early detection of cancer and monitoring the treatment of cancer patients. Applied BioCode's technology enables rapid and precise identification of cancer cells in blood or tissue, which can improve the effectiveness of treatment. Another important product of Applied BioCode is the BioCode Analyzer, an automated diagnostic instrument. The BioCode Analyzer is a high-throughput system capable of performing multiple tests simultaneously. The analyzer is equipped with a disposable chip that allows for quick and easy diagnosis. This makes the BioCode Analyzer a powerful tool for laboratory automation, providing fast and accurate diagnosis for a variety of diseases. Applied BioCode is also dedicated to researching and developing new technologies. The company has an active pipeline of new products and technologies to further improve diagnostic accuracy and the number of feasible tests. Applied BioCode is also developing new applications for its technologies to improve the diagnosis and treatment of diseases in various ways. In summary, Applied BioCode Corp plays an important role in the field of diagnostic technology. The company has developed a wide range of innovative diagnostic tests and instruments that enable diseases to be quickly and accurately detected. With its strong partnership with leading diagnostic automation system manufacturers and research organizations, Applied BioCode will continue to stay at the forefront and improve diagnostic practice. Applied BioCode é uma das empresas mais populares na Eulerpool.com.

Perguntas frequentes sobre ação Applied BioCode

Crescimento do EBIT Ano a Ano de Applied BioCode é 19,57 % em 2025.

Na Eulerpool você encontra o histórico completo do Applied BioCode de Crescimento do EBIT Ano a Ano desde 2006, com valores anuais, gráficos e análises detalhadas.

O crescimento do EBIT mede a mudança percentual no lucro operacional. Mostra se as operações principais de uma empresa estão se tornando mais lucrativas.

Para avaliar de Crescimento do EBIT Ano a Ano, é essencial compará-lo com pares do mesmo setor e indústria. Na Eulerpool, você pode encontrar comparações diretas de setor para Crescimento do EBIT Ano a Ano.

de Crescimento do EBIT Ano a Ano é um fator-chave para investidores. Mudanças nesta métrica podem sinalizar fundamentos em melhoria ou deterioração, impactando diretamente o preço das ações. Na Eulerpool, você pode acompanhar Applied BioCode de Crescimento do EBIT Ano a Ano historicamente e em tempo real.

Aceda a estes dados via API Eulerpool

100.000 pedidos/mês grátis · sem cartão

Crescimento — Applied BioCode

Todas as Métricas Financeiras — Applied BioCode